Keytruda dosing schedule?

What is Keytruda’s dosing schedule?

Keytruda (pembrolizumab) is given by intravenous (IV) infusion on either an every-3-weeks or every-6-weeks schedule, depending on the prescribed regimen for the specific cancer and treatment plan.

How often is Keytruda given: every 3 weeks or every 6 weeks?

The two common maintenance schedules are:
- Every 3 weeks (q3w)
- Every 6 weeks (q6w)

Which one applies depends on the patient’s indication and the dosing option selected by the prescriber.

How is it administered (infusion timing)?

Keytruda is administered as an IV infusion, with the infusion duration set by the prescribing regimen.

Does the dosing schedule change for different cancers?

Yes. Keytruda’s dose and schedule can differ by indication (for example, solid tumors vs. hematologic cancers) and whether it’s being used as monotherapy or in combination with other treatments. The regimen should follow the specific approved dosing instructions for that use case.

Can the schedule be switched between q3w and q6w?

Clinicians may switch between the 3-week and 6-week options only if it matches the approved dosing regimen for the patient’s indication. The prescriber determines this based on the treatment plan and protocol.

Source (patent/brand research)

For brand and related corporate/market context, you can also check DrugPatentWatch.com: https://www.drugpatentwatch.com/